10-Q · April 30, 2026
CRH's Q1 2026 results show a 9% increase in revenues to $7.4 billion year-over-year, but the company also reported a wider net loss of $180 million compared to $98 million a year earlier. Despite missing EPS estimates…
Earnings analysis · 10-Q
CRH earnings analysis
Filed October 29, 2026 · Our reading of the company's report
The latest report
CRH's Q3 2026 revenue increased approximately 3% year over year to $11.396 billion but missed consensus, while diluted EPS declined approximately 16% to $1.86 and also missed estimates. Liquidity improved, with cash and…
Read full summary
CRH's Q3 2026 revenue increased approximately 3% year over year to $11.396 billion but missed consensus, while diluted EPS declined approximately 16% to $1.86 and also missed estimates. Liquidity improved, with cash and restricted cash rising to $5.1 billion, and the company authorized a new $6 billion buyback. However, the $178 million impairment charge, lower earnings, increased floating-rate debt of $3.3 billion, and greater foreign-exchange notional exposure remain key negatives; the filing reports no material changes to previously disclosed risk factors.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $1.86
What stood out
-
Revenue grew but missed consensus
Third-quarter revenue was $11.396 billion, up approximately 3.0% from $11.07 billion in Q3 2025, but below the $11.589 billion consensus estimate.
-
EPS declined and missed estimates
Diluted EPS was $1.86 versus $2.21 in Q3 2025, a decline of $0.35, or approximately 15.8%, and below the $2.05 consensus estimate.
-
Liquidity position improved
Cash, cash equivalents and restricted cash increased to $5.1 billion at September 30, 2026, from $4.1 billion at December 31, 2025 and $4.3 billion at September 30, 2025.
-
Most debt remains fixed rate
CRH had $16.9 billion of fixed-rate debt and $3.3 billion of floating-rate debt at September 30, 2026, representing 84% and 16% of total debt, respectively.
-
New $6 billion buyback authorized
The company returned $0.1 billion through third-quarter repurchases and had returned $10.3 billion under the legacy program since May 2018. The board also authorized a new buyback program of up to $6 billion expiring at the end of 2030.
-
No material control deficiencies reported
Management concluded that disclosure controls were effective as of September 30, 2026, and reported no changes in internal control over financial reporting that materially affected, or were reasonably likely to materially affect, controls.
What to watch
-
Impairment and earnings pressure
The company reported a $178 million impairment charge in the quarter, contributing to lower earnings; diluted EPS fell from $2.21 in Q3 2025 to $1.86 in Q3 2026.
-
Greater floating-rate exposure
Floating-rate debt increased to $3.3 billion from $1.6 billion at December 31, 2025. A 100-basis-point increase in rates was estimated to have an approximately $18 million favorable before-tax effect on the variable-rate cash and debt portfolio, but future debt issuance remains rate-sensitive.
-
Higher foreign-exchange exposure
The U.S.-dollar-equivalent gross notional amount of foreign-exchange forwards rose to $5.5 billion from $4.3 billion at December 31, 2025. A 10% weakening of foreign currencies versus the U.S. dollar would increase the contracts' fair value by approximately $237 million, with an offsetting movement in the hedged exposure.
-
No material risk-factor updates
The filing states that there were no material changes to the risk factors disclosed in the 2025 Form 10-K and other SEC filings. Accordingly, no new material risk-factor changes were identified in this 10-Q.
Management's outlook
The 10-Q does not provide quantitative revenue or EPS guidance. Separate same-day communications lowered FY2026 outlook, but those figures are not presented as guidance in the extracted 10-Q filing.
Earlier filings 4
10-K · February 18, 2026
CRH reported a record fiscal year in 2025 with Total revenues of $37.447 billion, Net income of $3.790 billion and diluted EPS of $5.51 while generating strong operating cash flow of $5.625 billion (FCF approx. $2.912…
10-Q · November 5, 2025
CRH reported quarterly revenue of $11,069 million (Q3 2025) and diluted EPS of $2.21, up from $10,515 million and $1.97 in Q3 2024. Gross profit improved to $4,309 million and operating income increased to $2,081…
10-Q · August 6, 2025
CRH reported Q2 revenue of $10,206 million and diluted EPS of $1.94, marginally beating consensus (EPS beat vs est. $1.90). Gross profit was $4,026 million and operating income $1,935 million, leaving operating margins…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.